Clinical trials: Olaparib, completed
Advanced Solid Tumors
A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors
This is a Phase 1 study to assess the safety and clinical activity of RO7623066 alone and in combination in patients with advanced solid tumors.
- Trial name
- NCT05240898
- Testing
- RO7623066, Olaparib, Carboplatin
- Where
- 15 sites in United States
- Volunteers
- 116 people
- Sponsor
- Hoffmann-La Roche
Ovarian Cancer
Platine, Avastin and OLAparib in 1st Line
Randomized, Double-Blind, Phase III Trial of Olaparib vs. Placebo in Patients with Advanced FIGO Stage IIIB - IV High Grade Serous or Endometrioid Ovarian, Fallopian Tube, or Peritoneal Cancer treated with standard First-Line…
- Trial name
- PAOLA-1 (NCT02477644)
- Testing
- Olaparib
- Where
- 163 sites in Austria, Belgium and 9 more
- Volunteers
- 806 people
- Sponsor
- Arcagy Research